Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Update

Aptevo Therapeutics Inc. (NASDAQ:APVO) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 26,500 shares, a growth of 39.5% from the December 31st total of 19,000 shares. Based on an average trading volume of 265,800 shares, the short-interest ratio is currently 0.1 days. Approximately 1.8% of the shares of the stock are short sold.

Aptevo Therapeutics Stock Down 0.4 %

Shares of Aptevo Therapeutics stock traded down $0.02 on Friday, hitting $4.44. The stock had a trading volume of 8,713 shares, compared to its average volume of 61,881. Aptevo Therapeutics has a one year low of $3.65 and a one year high of $399.60. The stock’s 50-day simple moving average is $77.32 and its two-hundred day simple moving average is $295.41.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Aptevo Therapeutics in a report on Monday, December 9th. They issued a “sell” rating on the stock.

About Aptevo Therapeutics

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.